The recent 2019 European Society of Cardiology guidelines revised the clinical presentations of coronary artery disease (CAD) as either acute (acute coronary syndrome) or chronic (chronic coronary syndrome, CCS). Indeed, CAD is a dynamic process and can be modified by lifestyle, pharmacological therapies and revascularization, which can result in disease regression, stabilization or progression.
CCS is a major global cause of morbidity and mortality. Functional and anatomical noninvasive testing can identify patients with CCS who may benefit from revascularization. This can help reducing the burden and the risk of invasive angiography and better target invasive strategies. Different clinical scenarios can be encountered in patients with CCS, ranging from asymptomatic patients and patients with heart failure, to patients with typical anginal symptoms. However, for effective care, noninvasive testing needs to be accurate across all presentations.
Our aim is to refine current diagnostic schemes, and to improve prognostic and therapeutic outcome in patients with chronic coronary syndrome. This Research Topic in Frontiers in Cardiovascular Medicine is intended as a compendium of review articles and original research articles, providing a broad overview of the state-of-the-art role of non-invasive multimodality imaging in chronic coronary syndrome.
Suggested sub-themes include:
1) Test performance of non-invasive imaging tests for CAD.
2) Non-invasive imaging tests for CAD and outcomes.
3) Clinical likelihood of CAD and selection of a diagnostic test.
4) New roads in myocardial ischaemia testing using CMR: going beyond visual assessment.
5) Non-invasive imaging test for CAD: sex and ethnic differences.
6) Treatment effects on myocardial ischemia.
7) Coronary microcirculation and the role of non-invasive cardiovascular imaging.
8) Ischaemia testing in cardiomyopathies using Cardiac MRI (HCM, Fabry disease, DCM).
9) Techniques for automatic quantification of myocardial perfusion (e.g. machine learning).
The recent 2019 European Society of Cardiology guidelines revised the clinical presentations of coronary artery disease (CAD) as either acute (acute coronary syndrome) or chronic (chronic coronary syndrome, CCS). Indeed, CAD is a dynamic process and can be modified by lifestyle, pharmacological therapies and revascularization, which can result in disease regression, stabilization or progression.
CCS is a major global cause of morbidity and mortality. Functional and anatomical noninvasive testing can identify patients with CCS who may benefit from revascularization. This can help reducing the burden and the risk of invasive angiography and better target invasive strategies. Different clinical scenarios can be encountered in patients with CCS, ranging from asymptomatic patients and patients with heart failure, to patients with typical anginal symptoms. However, for effective care, noninvasive testing needs to be accurate across all presentations.
Our aim is to refine current diagnostic schemes, and to improve prognostic and therapeutic outcome in patients with chronic coronary syndrome. This Research Topic in Frontiers in Cardiovascular Medicine is intended as a compendium of review articles and original research articles, providing a broad overview of the state-of-the-art role of non-invasive multimodality imaging in chronic coronary syndrome.
Suggested sub-themes include:
1) Test performance of non-invasive imaging tests for CAD.
2) Non-invasive imaging tests for CAD and outcomes.
3) Clinical likelihood of CAD and selection of a diagnostic test.
4) New roads in myocardial ischaemia testing using CMR: going beyond visual assessment.
5) Non-invasive imaging test for CAD: sex and ethnic differences.
6) Treatment effects on myocardial ischemia.
7) Coronary microcirculation and the role of non-invasive cardiovascular imaging.
8) Ischaemia testing in cardiomyopathies using Cardiac MRI (HCM, Fabry disease, DCM).
9) Techniques for automatic quantification of myocardial perfusion (e.g. machine learning).
